FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely, to cardiac rheumatology and laboratory immune diagnostics, and can be used to predict the risk of decompensated heart failure (DHF) in patients with preserved (HFpEF) and midrange (HFmrEF) ejection fraction of the left ventricle against the background of rheumatoid arthritis (RA). Galectin-3 is determined in blood serum by enzyme immunoassay. If the value of galectin-3 is ≤15.1 pg/ml and risk factors such as intake of nonsteroidal anti-inflammatory agent, high blood pressure ≤140/90 mmHg, decreased glomerular filtration rate <90 ml/min/1.73 m2, and lipid metabolism disorder are combined in the patient, the risk of decompensated heart failure is predicted.
EFFECT: ensured prediction of the risk of DHF.
1 cl, 1 ex, 2 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
| METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
| METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC CONTRACTILITY MODULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION | 2023 |
|
RU2807230C1 |
| METHOD OF EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY-AKI IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE AND CHRONIC KIDNEY DISEASE | 2023 |
|
RU2812203C1 |
| METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
| METHOD FOR PREDICTION OF FATAL OUTCOME IN HOSPITAL PERIOD IN PATIENTS WITH CARDIAC FAILURE WITH MODERATELY REDUCED LEFT VENTRICULAR EJECTION FRACTION AFTER ACUTE DECOMPENSATION | 2023 |
|
RU2824980C1 |
| METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION ON THE BACKGROUND OF CARDIAC CONTRACTILITY MODULATION THERAPY | 2023 |
|
RU2804590C1 |
| METHOD FOR EARLY DIAGNOSIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES BY ANALYSIS OF HEART RATE VARIABILITY | 2023 |
|
RU2800862C1 |
| METHOD FOR PREVENTION OF THROMBOSIS IN INDIVIDUALS SUFFERING CARDIOVASCULAR DISEASES AND CHRONIC PAIN | 2013 |
|
RU2528904C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING UNFAVOURABLE CLINICAL COURSE OF HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION FOR 12 MONTHS | 2024 |
|
RU2826921C1 |
